COSCIENS Biopharma Inc. (CSCIF)

Market Cap	5.70M +8.2%
Revenue (ttm)	9.05M -4.0%
Net Income	-14.91M
EPS	-4.73
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	265
Average Volume	1,289
Open	1.880
Previous Close	1.880
Day's Range	1.750 - 1.880
52-Week Range	1.700 - 4.605
Beta	n/a
RSI	32.85
Earnings Date	Mar 25, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 40
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSCIF

Financial Performance

In 2024, COSCIENS Biopharma's revenue was $9.59 million, an increase of 34.22% compared to the previous year's $7.14 million. Losses were -$15.31 million, 339.3% more than in 2023.